ARCHIVES

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated

November 28, 1975

Without Advisor’s Input, Healy Approves Protocol For Gene Therapy

January 15, 1993

Cancer Letter Editor Finalist for Loeb Award

May 16, 2003

Rauscher Tells Flood Subcommittee How He Would Spend An Extra $50 Million-On Centers, Grants

April 5, 1974

AACI Opposes Most Guidelines Proposals But Can’t Agree On Research Based Ceiling

May 2, 1980

In Brief: Lucius Sinks New Cancer Centers Branch Chief; Mary Sears, One Of ASCO Founders, to Retire

May 11, 1984